コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 factor Helios, but its role in Treg function is still unknown.
2 in other organs, however, their role in CKD is still unknown.
3 er stroke, its precise neuroanatomical basis is still unknown.
4 are combined to assess an object's stiffness is still unknown.
5 ity for the development of psychotic illness is still unknown.
6 -H1 expressing tumor-reactive CD8(+) T cells is still unknown.
7 thout further degradation via beta-oxidation is still unknown.
8 KI) but without life-threatening indications is still unknown.
9 ffectiveness of emotional memory suppression is still unknown.
10 dysfunction in neocortical pyramidal neurons is still unknown.
11 m to modulate the composition of the capsule is still unknown.
12 gy plays a vital role during these processes is still unknown.
13 responses during visceral leishmaniasis (VL) is still unknown.
14 these chemicals through the use of teethers is still unknown.
15 However, the genetic basis is still unknown.
16 the detailed nature of these rearrangements is still unknown.
17 fect of TREM-1 on NLRP3 inflammasome and ALI is still unknown.
18 exact mechanism behind this satiating effect is still unknown.
19 torms will evolve in a future warmer climate is still unknown.
20 ugh their involvement in acquired resistance is still unknown.
21 ic silencing of the gene by a mechanism that is still unknown.
22 he physiological relevance of these findings is still unknown.
23 ce of IL-10 during M. tuberculosis infection is still unknown.
24 modes of transmission are exploited in vivo is still unknown.
25 f this interaction in prostate tumorigenesis is still unknown.
26 tionship between legalization and prevalence is still unknown.
27 NA depletion syndrome, the function of MPV17 is still unknown.
28 ostnatal growth, its precise biological role is still unknown.
29 lp explain such potent neurological activity is still unknown.
30 cular mechanism of (18)F-NaF vascular uptake is still unknown.
31 the amphipathic C-terminal tail of Atlastin is still unknown.
32 role in neighboring endothelial cells (ECs) is still unknown.
33 tion in the pathogenesis of bronchial asthma is still unknown.
34 ), the genetic cause for the majority of CSD is still unknown.
35 is critical for tumor growth and metastasis, is still unknown.
36 rocessing underlying interocular suppression is still unknown.
37 many mRNAs to their subcellular destinations is still unknown.
38 molecules of Dermatophagoides pteronyssinus is still unknown.
39 arrow cell-size distributions, its mechanism is still unknown.
40 oding sequences have functional consequences is still unknown.
41 type 2 diabetes patients, but the mechanism is still unknown.
42 c disorders are risk factors for reoffending is still unknown.
43 whether such cells represent stable subsets is still unknown.
44 , and function of circRNAs in vascular cells is still unknown.
45 e transcriptional regulation of this process is still unknown.
46 couples ATP hydrolysis to DNA translocation is still unknown.
47 r, the genome-wide regulatory role of GadEWX is still unknown.
48 se BRAF wild-type secondary malignant tumors is still unknown.
49 ce/Ace regulation under different conditions is still unknown.
50 How GAPDH binds to these AREs is still unknown.
51 arch, the mechanism of RGC death in glaucoma is still unknown.
52 ave and superconducting plasmonic structures is still unknown.
53 extent of protein loss and phosphoregulation is still unknown.
54 for this phytopathogen-dependent biocontrol is still unknown.
55 response conflicts also on a cognitive level is still unknown.
56 aetiology of this differing mutation pattern is still unknown.
57 A part of the full transcription bubble (TB) is still unknown.
58 the enzyme that catalyzes the C-U conversion is still unknown.
59 e donor cell death following transplantation is still unknown.
60 paB activation, but the underlying mechanism is still unknown.
61 cent hair bundle utilizes its active process is still unknown.
62 sPLA2-IIA-mediated S. aureus killing by host is still unknown.
63 (MH) and methylimidazole acetic acid (MIMA) is still unknown.
64 The underlying disease mechanism in TTS is still unknown.
65 mechanism by which they inactivate COP1/SPA is still unknown.
66 ulation on the cyt b5-P450 complex formation is still unknown.
67 wever the function of RUNX1 in breast cancer is still unknown.
68 + T cells on BECs under a low androgen level is still unknown.
69 ironment facilitate tumor cell intravasation is still unknown.
70 varian cancer, but its clinical significance is still unknown.
71 oteins help in generating [4Fe-4S] clusters, is still unknown.
72 underlying cellular and molecular mechanism is still unknown.
73 ctures directly penetrate the cell membrane, is still unknown.
74 ction, resolution, and adaptation), however, is still unknown.
75 The function of remaining subgroups is still unknown.
76 infection; however, the underlying mechanism is still unknown.
77 nto arogenate, but the identity of the genes is still unknown.
78 h is expressed in guard cells but whose role is still unknown.
79 ce of bacterial vaginosis (BV), its etiology is still unknown.
80 anges, and their effect on network function, is still unknown.
81 tion mechanism between bovicin HJ50 and BovK is still unknown.
82 urons in idiopathic Parkinson's disease (PD) is still unknown.
83 The nature of this dysfunction, however, is still unknown.
84 ic agent associated with the disease process is still unknown.
85 hese properties in three-dimensional culture is still unknown.
86 erent cell types; however, its role in VSMCs is still unknown.
87 tion of the Pairing homeologous 1 (Ph1) gene is still unknown.
88 How this traffic is organized and regulated is still unknown.
89 he NALP3 inflammasome or other inflammasomes is still unknown.
90 ce erroneous phylogenies for both strategies is still unknown.
91 ehavior of the first modern humans in Europe is still unknown.
92 le in mediating ethanol-induced GABA release is still unknown.
93 However, the target capture complex is still unknown.
94 hysiological function of NHERF dimerizations is still unknown.
95 se(s) responsible for dephosphorylating ABI5 is still unknown.
96 Biological function of these interactions is still unknown.
97 this task, and its underlying sensory basis, is still unknown.
98 ch food, but their behavior during digestion is still unknown.
99 c and dendritic synapses to spike inhibition is still unknown.
100 required to establish this tissue boundary, is still unknown.
101 rather well understood, but the role of DOG1 is still unknown.
102 unction in mammals and adult mammalian cells is still unknown.
103 ese cells contribute to CNS antigen drainage is still unknown.
104 ut whether they use the same Cav1.3 isoforms is still unknown.
105 age-related molecular alterations in plants is still unknown.
106 gan donation and graft function and survival is still unknown.
107 ween plant-herbivore-entomopathogenic fungi, is still unknown.
108 osome could be eliminated by this technology is still unknown.
109 er, the origin of its immunological activity is still unknown.
110 e mechanism by which the virus achieves this is still unknown.
111 however the mechanism underlying this effect is still unknown.
112 blockers on right ventricular (RV) function is still unknown.
113 ter, the largest planet in our Solar System, is still unknown.
114 response and NiV to acute lung injury (ALI) is still unknown.
115 how exactly RHD3 is involved in the process is still unknown.
116 e origin of this remarkable catalytic effect is still unknown.
117 infection, however its role in HCV infection is still unknown.
118 s diagnosed with major psychiatric disorders is still unknown.
119 ins participating in Abeta-induced signaling is still unknown.
120 ever, the role of STING in adaptive immunity is still unknown.
121 nerates these rhythms and their interactions is still unknown.
122 s mast cells, the underlying pathophysiology is still unknown.
123 However, the intimate mechanism is still unknown.
124 ed by limited availability of growth factors is still unknown.
125 pecific role in anthocyanin bioaccessibility is still unknown.
126 y and durability of this treatment over time is still unknown.
127 ow E. coli contributes to inflammation in UC is still unknown.
128 ibutes to the mechanism of neurodegeneration is still unknown.
129 d with this polymorphism in living organisms is still unknown.
130 of the frequency of weekly PA on weight loss is still unknown.
131 oles in apoptosis however, their role in AKI is still unknown.
132 ally regulated decrease in miR156 expression is still unknown.
133 nd bioactive properties beneficial to health is still unknown.
134 mechanism determining the reaction kinetics are still unknown.
135 d decreased height, but the causal mutations are still unknown.
136 obesity syndromes but its downstream targets are still unknown.
137 esults and their relative levels of accuracy are still unknown.
138 nd marine biodiversity distribution patterns are still unknown.
139 d by fire, and the long-term effects of fire are still unknown.
140 d which changes they trigger in the channel, are still unknown.
141 However, their mechanistic details are still unknown.
142 ever, the proteins involved in such transfer are still unknown.
143 e optimal acoustic settings for sonoporation are still unknown.
144 astrocyte diversity and circuit specificity are still unknown.
145 mechanisms behind this intriguing phenomenon are still unknown.
146 of the intermediates in the binding process are still unknown.
147 n and their possible interaction with CaV1.2 are still unknown.
148 pounds, whose complete biosynthetic pathways are still unknown.
149 design, and the responsible milk components are still unknown.
150 e responsible for anaerobic MTBE degradation are still unknown.
151 mechanisms driving epigenetic accessibility are still unknown.
152 tive computations to estimate values online, are still unknown.
153 ement; however, its impacts on N2O emissions are still unknown.
154 mediated oxidative stress in PD pathogenesis are still unknown.
155 markers for patient selection and monitoring are still unknown.
156 S/FOXO targets that regulate these functions are still unknown.
157 s relationship to other Alzheimer biomarkers are still unknown.
158 erformance, the electrode failure mechanisms are still unknown.
159 its further correlation with CSU phenotypes are still unknown.
160 tes, but the functions of most circular RNAs are still unknown.
161 oon size using second generation cryoballoon are still unknown.
162 the voltage change and interacts with anions are still unknown.
163 aining chromatin interactions; however, many are still unknown.
164 Yet the mechanisms of action are still unknown.
165 ccess of haematopoietic cell transplantation are still unknown.
166 rogress in proteomics most protein complexes are still unknown.
167 ng the temporal properties of tic expression are still unknown.
168 rocess, the underlying epigenetic mechanisms are still unknown.
169 derlying mechanisms and possible preventions are still unknown.
170 tic properties of this important interaction are still unknown.
171 c experiences toward the development of PTSD are still unknown.
172 such as mass and interaction cross sections are still unknown.
173 ctions and functions of these three proteins are still unknown.
174 act mechanisms regulating vascular integrity are still unknown.
175 insensitivity in patients with severe asthma are still unknown.
176 nt in Asians and its functional consequences are still unknown.
177 al wasting syndrome; however, the mechanisms are still unknown.
178 sory neurons responsible for these functions are still unknown.
179 difficult to infer, and in most species they are still unknown.
180 wever, the mechanisms underlying its effects are still unknown.
181 cells that sustain virus replication in vivo are still unknown.
182 e mechanisms of microtubule hyperacetylation are still unknown.
183 nd other potential pathways to glycosylation are still unknown.
184 ion with their specific chemical composition are still unknown.
185 free-operant instrumental avoidance behavior are still unknown.
186 rmation processing by the vomeronasal system are still unknown.
187 s regulating FXR expression in the intestine are still unknown.
188 tructure and/or biological function of which are still unknown.
189 or the Study of the Liver (APASL) guidelines are still unknown.
190 rocesses, the effects of lidocaine in sepsis are still unknown.
191 ic cells and massive intestinal inflammation are still unknown.
192 reates a painful experience from nociception are still unknown.
193 Etiology and specific causes, however, are still unknown.
194 The underlying mechanisms are still unknown.
195 lthough the underlying biological mechanisms are still unknown.
196 ing several central RNA processing functions are still unknown.
197 Critical steps in this degenerative process are still unknown.
198 y motor cortex (M1) in these early movements are still unknown.
199 in and distribution in this biological fluid are still unknown.
200 onsequences of infection on a per-cell basis are still unknown.
201 physiological underpinnings of these effects are still unknown.
202 PKA action on neurite sprouting and activity are still unknown.
203 elements controlling de novo HSC generation are still unknown.
204 this debilitating neuropsychiatric disorder are still unknown.
205 ected but the cause and effect relationships are still unknown.
206 potential effect of microbiota in the liver are still unknown.
207 ogens reorganize the healthy oral microbiome are still unknown.
208 However, their computational functions are still unknown.
209 , the mechanisms underlying this association are still unknown.
210 g processing and epitope presentation to CTL are still unknown.
211 and indeed the localization of these changes are still unknown.
212 splicing branchpoints, but many branchpoints are still unknown.
213 this 9p21 DNA variant to cardiovascular risk are still unknown.
214 ar mechanisms underlying FGFR2-mediated risk are still unknown.
215 or functional mutations in other genes that are still unknown.
216 ed prior knowledge serving these predictions are still unknown.
217 ical roles in the female reproductive system are still unknown.
218 nd many, possibly most, of the disease genes are still unknown.
219 These pathways are still unknown.
220 gnals involved in these demographic declines are still unknown.
221 ncertainty, the underlying neural mechanisms are still unknown.
222 nd temporal occurrence in the disease course are still unknown.
223 itional, nonenzymatic factors, some of which are still unknown.
224 ponsible for pro-OCN cleavage in osteoblasts are still unknown.
225 y syndrome coronavirus (MERS-CoV) infections are still unknown.
226 this phenomenon but responsible compound(s) are still unknown.
227 ispose to rhabdoid tumors versus schwannomas are still unknown.
228 s platelets to respond to subsequent stimuli are still unknown.
229 iological role of mitochondria-bound tubulin are still unknown.
230 eractions of many deep-sea pelagic organisms are still unknown.
231 owever, the mechanisms driving these defects are still unknown.
232 riations in mycobacterial strains themselves are still unknown.
233 lammation and synaptic alterations in MS/EAE are still unknown.
234 he onset and the spreading of these diseases are still unknown.
235 ch cognitive functioning seems preponderant, are still unknown.
236 ents underlying the gating of these channels are still unknown.
237 ition of clouds and its formation mechanisms are still unknown.
238 cular mechanism of amino acid phloem loading was still unknown.
239 act with particular viral RNAs, most of them being still unknown.
240 in almost half of human lung adenocarcinomas is still unknown, a fact that complicates the developmen
242 fibrillation is extensively documented, much is still unknown about the formation of these Abeta aggr
243 suppressor for ovarian cancer; however much is still unknown about the in vivo roles of CDK12/Cyclin
244 el with which to study NiV disease, but much is still unknown about the viral determinants of NiV pat
245 for banned or restricted chemicals, but much is still unknown about their metabolism and occurrence i
246 d its potential role as a therapeutic target are still unknown, although it has been reported that hu
247 echanism of voriconazole-induced skin cancer is still unknown and may involve its primary metabolite,
248 te feedback of such greenhouse gas emissions is still unknown and may to a large extent depend on the
250 voltage-gated potassium channels lead to EA is still unknown and there is no consistent pharmacologi
251 e., 3,152) of all known Mendelian phenotypes are still unknown, and many more Mendelian conditions ha
252 of patients with PPGL-polycythemia syndromes is still unknown, and because these tumors (in most pati
253 However, the optimal temperature for HT is still unknown, and few preclinical studies have compa
254 e codon being decoded in ribosome footprints is still unknown, and has been complicated by the recent
255 ast growth factor receptor 2 (FGFR2) kinase, is still unknown, as the numerous crystal structures of
257 on mechanism of volatile general anesthetics is still unknown despite their effect has been clinicall
258 direction and magnitude of net forest change is still unknown due to the large uncertainties in satel
259 However, the total number of human proteins is still unknown due to the prevalence of alternative sp
262 SICM, several aspects of the imaging process are still unknown; for example, there is still no accura
265 genesis have been identified and studied, it is still unknown how genetic and molecular regulation of
268 especially in their structural analysis, it is still unknown how the substrate stimulates ATP hydrol
272 le of bacterial capsules in pathogenesis, it is still unknown if systemic cues such as the cell cycle
275 chanism by which the inflammasome senses ROS is still unknown in podocytes upon hHcys stimulation.
277 he Cx43 residues that undergo ubiquitination are still unknown, in this study we address other unreso
278 erminants of ligand gating in these channels are still unknown, mainly because of a lack of direct st
279 anism of how these mutations lead to disease is still unknown, much knowledge has been gained about f
280 of the Cav1.233L channels in neonatal heart is still unknown, our report demonstrates the ability of
284 Although the molecular mechanistic link is still unknown, the question whether or not acetaminop
285 in congeners exert their inhalatory toxicity is still unknown, this represents a step toward demonstr
287 However, the reasons of this variability are still unknown.We have characterized the structure of
296 ess, Polytomella spp. have a plastid, but it is still unknown whether they harbor a plastid genome.
297 been documented in peripheral axons, but it is still unknown whether this localized organelle partic
298 ormation of abnormal discs is unclear and it is still unknown whether this mutant pigment can mediate
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。